My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 516

    1.

    Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enoxaparin Clinical Trial Group.

    Spiro TE, Johnson GJ, Christie MJ, Lyons RM, MacFarlane DE, Blasier RB, Tremaine MD.

    Ann Intern Med. 1994 Jul 15;121(2):81-9.PMID: 8017740 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.

    Colwell CW Jr, Spiro TE, Trowbridge AA, Morris BA, Kwaan HC, Blaha JD, Comerota AJ, Skoutakis VA.

    J Bone Joint Surg Am. 1994 Jan;76(1):3-14. Erratum in: J Bone Joint Surg Am 1994 Mar;76(3):4741. PMID: 8288662 [PubMed - indexed for MEDLINE]Related articles

    3.

    Efficacy and safety of postdischarge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement. A prospective randomised double-blind placebo-controlled trial.

    Planes A, Vochelle N, Darmon JY, Fagola M, Bellaud M, Compan D, Saliba E, Weisslinger N, Huet Y.

    Drugs. 1996;52 Suppl 7:47-54.PMID: 9042560 [PubMed - indexed for MEDLINE]Related articles

    4.

    Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.

    Levine MN, Hirsh J, Gent M, Turpie AG, Leclerc J, Powers PJ, Jay RM, Neemeh J.

    Ann Intern Med. 1991 Apr 1;114(7):545-51.PMID: 1848054 [PubMed - indexed for MEDLINE]Related articles

    5.

    Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement.

    Bergqvist D, Benoni G, Björgell O, Fredin H, Hedlundh U, Nicolas S, Nilsson P, Nylander G.

    N Engl J Med. 1996 Sep 5;335(10):696-700.PMID: 8703168 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease.

    Merli G, Spiro TE, Olsson CG, Abildgaard U, Davidson BL, Eldor A, Elias D, Grigg A, Musset D, Rodgers GM, Trowbridge AA, Yusen RD, Zawilska K; Enoxaparin Clinical Trial Group.

    Ann Intern Med. 2001 Feb 6;134(3):191-202.PMID: 11177331 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo.

    Planes A, Vochelle N, Darmon JY, Fagola M, Bellaud M, Huet Y.

    Lancet. 1996 Jul 27;348(9022):224-8.PMID: 8684199 [PubMed - indexed for MEDLINE]Related articles

    8.

    Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement.

    Planes A, Vochelle N, Mazas F, Mansat C, Zucman J, Landais A, Pascariello JC, Weill D, Butel J.

    Thromb Haemost. 1988 Dec 22;60(3):407-10.PMID: 2853459 [PubMed - indexed for MEDLINE]Related articles

    9.

    Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Enoxaparin Clinical Trial Group.

    Colwell CW Jr, Spiro TE, Trowbridge AA, Stephens JW, Gardiner GA Jr, Ritter MA.

    Clin Orthop Relat Res. 1995 Dec;(321):19-27.PMID: 7497668 [PubMed - indexed for MEDLINE]Related articles

    10.

    Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.

    Fitzgerald RH Jr, Spiro TE, Trowbridge AA, Gardiner GA Jr, Whitsett TL, O'Connell MB, Ohar JA, Young TR; Enoxaparin Clinical Trial Group.

    J Bone Joint Surg Am. 2001 Jun;83-A(6):900-6.PMID: 11407799 [PubMed - indexed for MEDLINE]Related articles

    11.

    A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.

    Bergmann JF, Neuhart E.

    Thromb Haemost. 1996 Oct;76(4):529-34.PMID: 8902991 [PubMed - indexed for MEDLINE]Related articles

    12.

    Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study.

    Heit JA, Colwell CW, Francis CW, Ginsberg JS, Berkowitz SD, Whipple J, Peters G; AstraZeneca Arthroplasty Study Group.

    Arch Intern Med. 2001 Oct 8;161(18):2215-21.PMID: 11575978 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin.

    Eriksson BI, Kälebo P, Anthymyr BA, Wadenvik H, Tengborn L, Risberg B.

    J Bone Joint Surg Am. 1991 Apr;73(4):484-93.PMID: 2013587 [PubMed - indexed for MEDLINE]Related articles

    14.

    Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.

    Büller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob G, Segers AE, Cariou R, Leeuwenkamp O, Lensing AW; Matisse Investigators.

    Ann Intern Med. 2004 Jun 1;140(11):867-73.PMID: 15172900 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge.

    Colwell CW Jr, Collis DK, Paulson R, McCutchen JW, Bigler GT, Lutz S, Hardwick ME.

    J Bone Joint Surg Am. 1999 Jul;81(7):932-40.PMID: 10428124 [PubMed - indexed for MEDLINE]Related articles

    16.

    A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement.

    Eriksson BI, Wille-Jørgensen P, Kälebo P, Mouret P, Rosencher N, Bösch P, Baur M, Ekman S, Bach D, Lindbratt S, Close P.

    N Engl J Med. 1997 Nov 6;337(19):1329-35.PMID: 9358126 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.

    Bauer KA, Eriksson BI, Lassen MR, Turpie AG; Steering Committee of the Pentasaccharide in Major Knee Surgery Study.

    N Engl J Med. 2001 Nov 1;345(18):1305-10.PMID: 11794149 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.

    Horbach T, Wolf H, Michaelis HC, Wagner W, Hoffmann A, Schmidt A, Beck H.

    Thromb Haemost. 1996 Feb;75(2):246-50.PMID: 8815569 [PubMed - indexed for MEDLINE]Related articles

    19.

    Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.

    Turpie AG, Bauer KA, Eriksson BI, Lassen MR.

    Arch Intern Med. 2002 Sep 9;162(16):1833-40.PMID: 12196081 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    A short course of low-molecular-weight heparin to prevent deep venous thrombosis after elective total hip replacement.

    Gallay S, Waddell JP, Cardella P, Morton J.

    Can J Surg. 1997 Apr;40(2):119-23.PMID: 9126125 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity